Cabaletta Bio, Inc. (CABA) › Cash & EquivalentsCabaletta Bio, Inc. (CABA) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $33.02M2019: $136.20M2020: $101.43M2021: $122.22M2022: $81.61M2023: $193.24M2024: $163.96M2025: $82.98M$82.98M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$82.98M-49.4%2024$163.96M-15.2%2023$193.24M+136.8%2022$81.61M-33.2%2021$122.22M+20.5%2020$101.43M-25.5%2019$136.20M+312.5%2018$33.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share